artificial intelligence machine learning deep learning rules regulations US Food and Drug Administration FDA American Medical Informatics Association AMIA algorithm announcement framework Scott Gottlieb medical devices Dr. Norman Sharpless medicine science technology AIMed discussion paper deadline

AMIA’s suggestions to the upcoming FDA AI Framework

This April, the US Food and Drug Administration (FDA) Commissioner, Scott Gottlieb, announced the steps to consider a new regulatory framework targeting at artificial intelligence (AI) driven medical devices. In the announcement, Gottlieb acknowledged the impacts of AI algorithms in providing treatment suggestions and assisting in the screening of certain medical conditions. In fact, as of…